Cannabis Science Groundbreaking Cancer Research Skyrockets …

IRVINE, CA, Feb. 22, 2018 (GLOBE NEWSWIRE) — Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is very pleased to report the Company’s groundbreaking laboratory research with Dana-Farber Cancer Institute using Nanoparticle Drone technology and Cannabinoids to successfully kill cancer cells has now reached a serious level of attention. The Cannabis Science Dana-Farber research team has now begun next level planning to bring this efficacious research to full commercialization.

At this point this cutting-edge research has more views than 95% of all Frontiers articles.

Published in September 2017, Cannabis Science’s peer-reviewed article in Frontiers in Oncology, “Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids”, has been viewed more than 9,800 times, representing an increase in views of nearly 50% since December 2017.

Frontiers Impact: http://loop-impact.frontiersin.org/impact/article/290549#totalviews/views

Frontiers of Oncology: https://www.frontiersin.org/articles/10.3389/fonc.2017.00208/full

“This strong – and increasing – level of interest by our colleagues validates the importance

... read more at: https://globenewswire.com/news-release/2018/02/22/1379809/0/en/Cannabis-Science-Groundbreaking-Cancer-Research-Skyrockets-With-More-Views-Than-95-of-All-Frontiers-Articles-Research-Team-Begins-Evaluating-Commercialization-Options.html

by

Leave a Reply

Your email address will not be published. Required fields are marked *